secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ainos, Inc. (AIMD)
CIK:        0001014763
Form:       8-K
Filed at:   2024-03-08T23:59:59+00:00
Accession:  0001654954-24-002898
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ainos reports FY2023 revenue drop to $122K; net loss $13.8M
-----------------------------------------------------------

- Revenue fell 97% to $122,112 from $3.52M in 2022, driven by COVID-19 test kit sales decline.
- Gross loss of $253,733 vs positive gross profit of $1.4M a year earlier; net loss $13.77M vs $14.01M.
- Cash and cash equivalents $1.89M at Dec 31, 2023, nearly flat from $1.85M at Dec 31, 2022.
- R&D expenses rose to $7.32M; SG&A fell to $5.64M on lower share-based compensation.
- Strategic pivot: advancing VELDONA Phase III, AI Nose VOC platform with NISD & Inabata, and pet supplement sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1014763/000165495424002898/0001654954-24-002898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1014763/000165495424002898/aimd_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-002898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer